David C. Calvin

888 total citations
12 papers, 729 citations indexed

About

David C. Calvin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, David C. Calvin has authored 12 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in David C. Calvin's work include Sexual function and dysfunction studies (3 papers), Hormonal and reproductive studies (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). David C. Calvin is often cited by papers focused on Sexual function and dysfunction studies (3 papers), Hormonal and reproductive studies (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). David C. Calvin collaborates with scholars based in United States and Italy. David C. Calvin's co-authors include Sabra L. Klein, Arthur L. Burnett, Randy J. Nelson, Valina L. Dawson, Jian‐Xiang Liu, Lance J. Kriegsfeld, Gregory E. Demas, Richard I. Silver, Dennis S. Peppas and Steven G. Docimo and has published in prestigious journals such as Nature Medicine, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

David C. Calvin

12 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Calvin United States 10 272 193 192 177 123 12 729
Fredrik Holmquist Sweden 21 567 2.1× 515 2.7× 268 1.4× 336 1.9× 264 2.1× 39 1.4k
Robyn E. Becker United States 9 460 1.7× 437 2.3× 258 1.3× 198 1.1× 133 1.1× 9 918
George F. Lasker United States 15 261 1.0× 139 0.7× 85 0.4× 190 1.1× 86 0.7× 30 663
Diana C. Márquez United States 9 202 0.7× 225 1.2× 345 1.8× 89 0.5× 87 0.7× 13 929
Kotomi Fujishige Japan 19 258 0.9× 93 0.5× 1.2k 6.2× 47 0.3× 187 1.5× 23 1.4k
Jessica Moline United States 16 260 1.0× 222 1.2× 279 1.5× 15 0.1× 84 0.7× 28 1.1k
Xiang Cai China 12 69 0.3× 93 0.5× 139 0.7× 57 0.3× 32 0.3× 22 546
Medardo Hernández Spain 22 265 1.0× 270 1.4× 221 1.2× 504 2.8× 346 2.8× 68 1.2k
Mark Pullen United States 20 42 0.2× 88 0.5× 377 2.0× 63 0.4× 458 3.7× 43 1.0k
Michael L. Pucci United States 19 298 1.1× 39 0.2× 211 1.1× 17 0.1× 165 1.3× 27 1.0k

Countries citing papers authored by David C. Calvin

Since Specialization
Citations

This map shows the geographic impact of David C. Calvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Calvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Calvin more than expected).

Fields of papers citing papers by David C. Calvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Calvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Calvin. The network helps show where David C. Calvin may publish in the future.

Co-authorship network of co-authors of David C. Calvin

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Calvin. A scholar is included among the top collaborators of David C. Calvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Calvin. David C. Calvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ferraris, Dana, Sergei A. Belyakov, Weixing Li, et al.. (2007). Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV). Current Topics in Medicinal Chemistry. 7(6). 597–608. 22 indexed citations
2.
Ewert, Alan, et al.. (2007). Outdoor programs and environmental beliefs: Investigating the stability of outcomes and levels of salience. 49. 2 indexed citations
3.
Thomas, Ajit G., Krystyna M. Wozniak, Takashi Tsukamoto, et al.. (2006). Glutamate Carboxypeptidase II (NAALADase) Inhibition as a Novel Therapeutic Strategy. Advances in experimental medicine and biology. 576. 327–337. 23 indexed citations
4.
Tsukamoto, Takashi, Pavel Majer, Dilrukshi Vitharana, et al.. (2005). Enantiospecificity of Glutamate Carboxypeptidase II Inhibition. Journal of Medicinal Chemistry. 48(7). 2319–2324. 20 indexed citations
5.
Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2005). Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors. International Journal of Oncology. 26(2). 415–22. 33 indexed citations
6.
Ferraris, Dana, David C. Calvin, Bert E. Thomas, et al.. (2004). Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(22). 5579–5583. 19 indexed citations
7.
Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2004). Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site. Cineca Institutional Research Information System (Tor Vergata University). 45. 2007. 1 indexed citations
8.
Tiffany, Carol W., et al.. (1999). Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase. The Prostate. 39(1). 28–35. 75 indexed citations
9.
Burnett, Arthur L., Lance J. Kriegsfeld, Sabra L. Klein, et al.. (1998). Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. Nature Medicine. 4(1). 84–87. 93 indexed citations
10.
Burnett, Arthur L., David C. Calvin, Jian‐Xiang Liu, et al.. (1997). Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nature Medicine. 3(5). 571–574. 124 indexed citations
11.
Burnett, Arthur L., David C. Calvin, Richard I. Silver, Dennis S. Peppas, & Steven G. Docimo. (1997). Immunohistochemical Description of Nitric Oxide Synthase Isoforms in Human Clitoris. The Journal of Urology. 158(1). 75–78. 130 indexed citations
12.
Burnett, Arthur L., Randy J. Nelson, David C. Calvin, et al.. (1996). Nitric Oxide-Dependent Penile Erection in Mice Lacking Neuronal Nitric Oxide Synthase. Molecular Medicine. 2(3). 288–296. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026